ArticleNeurology. Clinical practice2013
Reading a cost-effectiveness or decision analysis study: Five things to consider.
Article in Neurology. Clinical practice, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 11 citations in OpenAlex.
- Cost-effectiveness of community-based interventions for type 2 diabetes management in Indonesia: a time-horizon sensitivity analysis.Cost effectiveness and resource allocation : C/E · 2026Article
- Modelling cost-effectiveness of replacement strategies for ambulance services in the Ministry of Health Malaysia.BMC health services research · 2024Article
- Economic study of the value of expanding HCV treatment capacity in Germany.BMJ open gastroenterology · 2017Article
- The cost-utility of CT angiography and conventional angiography for people presenting with intracerebral hemorrhage.PloS one · 2014Article
- Cost-effectiveness analyses: Beauty and the beast?Neurology. Clinical practice · 2013Article
- Cost-effectiveness data: Are neurologists in practice equipped to interpret them?Neurology. Clinical practice · 2013Article
Corrections and comments
- Commented on by
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cost-effectiveness studies and decision analyses of neurologic practices, treatments, and technologies are increasing in the literature and have an emerging role within both medicine and neurology. Knowledge about these research approaches, how to interpret the results of such studies, as well as an understanding of their limitations will be of growing importance for the practicing neurologist. We discuss 5 aspects of these analyses to increase awareness about the uses and limitations of cost-effectiveness articles in everyday practice.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.